Traveling for Care?
Whether you're crossing the country or the globe, we make it easy to access world-class care at Johns Hopkins.
Our team takes a proactive approach to following patients closely for recurrent disease. We believe that it may make a difference in prolonging life and maintaining quality of life if we catch recurrent tumors earlier and treat them effectively. Follow-up appointments are made every three months for the first two to three years, every six months up to 5 years after diagnosis and yearly thereafter.
CA125 is a non-specific blood test that can be abnormal in patients with ovarian cancer as well as many non-cancerous conditions including inflammation of the peritoneal surface. For women who previously have not been diagnosed with ovarian cancer, elevated CA125 could be anything from endometriosis or a bladder infection to presence of menstrual period. It is approved by the FDA as a means of monitoring ovarian cancer, but should not be used as a screening test for the disease, particularly in pre-menopausal women. Currently, the morphologic or anatomical characteristics of the ovary, as seen by ultrasound or computed tomography, are the most accurate means for evaluating a suspected ovarian cancer.
Answers to your general questions on a variety of ovarian cancer topics.